Log In
Print
BCIQ
Print
Print this Print this
 

POL6326

  Manage Alerts
Collapse Summary General Information
Company Polyphor Ltd.
DescriptionCXC chemokine receptor 4 (CXCR4) inhibitor
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase II
Standard IndicationStem cell transplant
Indication DetailsHematopoietic stem cell transplant (HSCT)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today